Streetbeat News

Stock Prices

TFIN

Triumph Financial (NASDAQ:TFIN) reported Q2 2024 earnings per share (EPS) of $0.08, missing the analyst consensus estimate of $0.22 by 63.64%. However, the company reported sales of $105.082 million, beating the estimate of $104.076 million by 0.97%. This represents a 2.06% increase over the same period last year.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2024 | 8:11 pm

EFX

Equifax (NYSE:EFX) reported Q2 earnings per share (EPS) of $1.82, surpassing the analyst consensus estimate of $1.73 by 5.2%. This marks a 6.43% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2024 | 8:10 pm

LESL

Leslie's Inc. (LESL) announced preliminary sales for Q3 of approximately $570 million, falling short of the estimated $615.407 million. The company also expects adjusted EPS to be between $0.32 and $0.33, below the estimated $0.42.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2024 | 8:10 pm

DIA

DYLG

ELV

IHF

IYH

UNH

XLV

Healthcare investors are anticipating that a potential Trump administration could ease regulations on Medicare Advantage, which may benefit health insurers like UnitedHealth, Cigna, and Humana. This expectation has led to mixed results in the health insurance sector, with some stocks rising and others falling. ETFs holding health insurer stocks have generally trended upward.

Portfolio Pulse from Michael Juliano

July 17, 2024 | 8:09 pm

LESL

Leslie's Inc. reported that its Q3 results were impacted by unfavorable weather in April and May, which delayed the start of the pool season. The company expects preliminary sales of approximately $570 million, gross profit of $228 to $229 million, and a gross margin of around 40%. Net income is projected to be $56 to $58 million, with adjusted EBITDA of $108 to $109 million, adjusted net income of $59 to $60 million, and adjusted diluted earnings per share of $0.32 to $0.33.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2024 | 8:08 pm

KMI

Kinder Morgan shares are trading lower following worse-than-expected Q2 earnings.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2024 | 8:07 pm

RARE

Ultragenyx has reached an agreement with the FDA on the endpoints for its Phase 3 study of GTX-102. The Phase 3 study is set to begin by the end of the year, following a successful end-of-Phase 2 meeting. The study will be a global double-blind sham-controlled pivotal study, with an additional study planned for patients with other mutations.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2024 | 8:06 pm

CHUY

DRI

Darden Restaurants (NYSE:DRI) will acquire Chuy's Holdings (NASDAQ:CHUY) for $37.50 per share in an all-cash transaction valued at approximately $605 million. This acquisition will add Chuy's 101 Tex-Mex restaurants to Darden's portfolio of brands.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2024 | 8:06 pm

KMI

Kinder Morgan (NYSE:KMI) reported Q2 2024 earnings of $0.25 per share, missing the analyst estimate of $0.26. Sales were $3.572 billion, also missing the $4.123 billion estimate. Despite the misses, sales increased by 2.03% year-over-year.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2024 | 8:06 pm

DDOG

GTLB

Datadog Inc. (NASDAQ:DDOG) shares are trading lower following reports of a potential acquisition of GitLab Inc. (NASDAQ:GTLB), valued at approximately $8 billion. Both companies and Alphabet, a significant GitLab stakeholder, have declined to comment. Analyst Mike Cikos suggests the acquisition could be beneficial despite AWS or Google Cloud being seen as more obvious buyers.

Portfolio Pulse from Vaishali Prayag

July 17, 2024 | 8:05 pm